Related Experiment Video
Updated: Jan 28, 2026

Quantification of Immunostained Caspase-9 in Retinal Tissue
Published on: July 25, 2022
The involvement of matrix metalloproteinases 2 and 9 in rat retinal ischemia
Nurit Mathalone1, Nitza Lahat, Michal A Rahat
1Department of Ophthalmology, Carmel Medical Center, 7 Michal Street, Haifa, 34362, Israel.
Background:
The involvement of matrix metalloproteinases (MMPs) in ischemic tissue damage and remodeling has been reported by many investigators. Our study was designed to investigate the involvement of MMPs and of tissue inhibitors of metalloproteinases (TIMPs) in rat retinal ischemic injury, the effect of nitric oxide synthase (NOS) inhibitors on MMPs' activity in this model and whether minocycline (an MMP inhibitor) is protective in retinal ischemia.
Methods:
Ninety-four rats were used in the study. Ischemia was induced by 90 min elevation of intraocular pressure. MMPs' activities and the effect of NOS inhibitors [aminoguanidine (AG) or N-nitro-L-arginine (NNA)] and minocycline on MMPs' activities were assessed by zymography and TIMPs expression by Western analysis. Morphological damage was quantified by morphometry of hematoxylin and eosin-stained retinal sections.
Results:
Retinal extracts exhibited activities of proMMP-9 and proMMP-2. The activity of proMMP-9 increased immediately post ischemia (PI) and peaked to 4.6 times that of normal untreated controls in ischemic retinas and to 2.6 times that of controls in retinas of fellow sham-treated eyes at 24 h PI. The relative amount of TIMP-1 increased to 1.9-fold following ischemia and 2.5-fold in fellow sham-treated eyes at 24 h PI. ProMMP-2 activity increased more than two-fold immediately, at 24 h and at 48 h PI in ischemic retinas, and insignificantly in fellow sham-treated eyes. Treatment with 25 mg/kg AG or NNA caused a non-significant increase in proMMP-9 activity at 24 h PI (3.7- and 2.9-fold, respectively, p>0.6). There was no effect of AG or NNA on the activity of proMMP-2. Minocycline significantly attenuated the retinal ischemic damage, primarily by partially preserving ganglion cells and the inner plexiform layer. Minocyline (0.5 mg/ml or 5 mg/ml) inhibited MMPs' activities in ischemic retinal extracts in vitro.
Conclusions:
MMPs participated in morphological ischemic damage to rat retina. Treatment with minocycline dramatically attenuated damage to the retina.
Insights
Matrix metalloproteinases (MMPs) contribute to retinal ischemic damage. Minocycline, an MMP inhibitor, significantly reduced this damage, preserving retinal cells and layers in a rat model.
Area of Science:
- Ophthalmology
- Neuroscience
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are implicated in ischemic tissue injury and remodeling.
- Investigating MMPs and tissue inhibitors of metalloproteinases (TIMPs) in rat retinal ischemia is crucial.
- Understanding the role of nitric oxide synthase (NOS) inhibitors and minocycline in this model is essential.
Purpose of the Study:
- To investigate MMP and TIMP involvement in rat retinal ischemic injury.
- To assess the effect of NOS inhibitors on MMP activity in retinal ischemia.
- To determine if minocycline, an MMP inhibitor, offers protection against retinal ischemia.
Main Methods:
- Induction of ischemia via elevated intraocular pressure in 90 rats.
- Assessment of MMP activity using zymography and TIMP expression via Western analysis.
- Quantification of morphological damage through retinal section morphometry.
Main Results:
- ProMMP-9 activity significantly increased post-ischemia, peaking at 4.6 times control levels.
- ProMMP-2 activity also increased in ischemic retinas.
- Minocycline treatment significantly attenuated retinal damage, preserving key retinal layers.
Conclusions:
- MMPs play a role in the morphological damage caused by retinal ischemia.
- Minocycline demonstrates significant protective effects against retinal ischemic injury.
Related Concept Videos
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
The Bone Matrix
Extracellular Matrix
Matrix Proteoglycans and Glycoproteins

